EMD-55722

Single-particle
3.09 Å
EMD-55722
3D View Gallery
Deposition: 16/11/2025
Map released: 28/01/2026
Last modified: 28/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-55722

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9t9m summary report (pdf.gz) Map-9t9m FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Tilvestamab Fab bound to the anti-Fab nanobody

EMD-55722

Single-particle
3.09 Å
EMD-55722
3D View Gallery
Deposition: 16/11/2025
Map released: 28/01/2026
Last modified: 28/01/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Homo sapiens, Mus sp.
Sample: Tilvestamab Fab and the antiNabFab nanobody
Fitted models: 9t9m

Deposition Authors: Lopez AJ, Christakou E, Kursula P
Structural Analysis of Tilvestamab in Complex with AXL.
Christakou E, Lopez AJ, Muruganandam G , Micklem D, Lorens JB, Kursula P
(2026) Acs Omega , 11 , 1874 - 1882
PUBMED: 41552498
DOI: doi:10.1021/acsomega.5c10003
ISSN: 2470-1343
Grant Support: